Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.09 CNY
3.77 B CNY
259.56 B CNY
926.18 M
About SHANGHAI PHARMACEUTICALS HOLDING
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research and development, manufacture, distribution, and retail of pharmaceutical products. The company was founded on January 18, 1994 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 601607 is 21.37 CNY — it has decreased by −2.07% in the past 24 hours. Watch SHANGHAI PHARMACEUTICALS HOLDING stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI PHARMACEUTICALS HOLDING stocks are traded under the ticker 601607.
601607 stock has fallen by −1.34% compared to the previous week, the month change is a 10.02% rise, over the last year SHANGHAI PHARMACEUTICALS HOLDING has showed a 19.05% increase.
We've gathered analysts' opinions on SHANGHAI PHARMACEUTICALS HOLDING future price: according to them, 601607 price has a max estimate of 24.90 CNY and a min estimate of 13.60 CNY. Watch 601607 chart and read a more detailed SHANGHAI PHARMACEUTICALS HOLDING stock forecast: see what analysts think of SHANGHAI PHARMACEUTICALS HOLDING and suggest that you do with its stocks.
601607 reached its all-time high on May 18, 2015 with the price of 32.10 CNY, and its all-time low was 9.69 CNY and was reached on Jun 25, 2013. View more price dynamics on 601607 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
601607 stock is 1.27% volatile and has beta coefficient of 0.53. Track SHANGHAI PHARMACEUTICALS HOLDING stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI PHARMACEUTICALS HOLDING there?
Today SHANGHAI PHARMACEUTICALS HOLDING has the market capitalization of 78.91 B, it has increased by 5.01% over the last week.
Yes, you can track SHANGHAI PHARMACEUTICALS HOLDING financials in yearly and quarterly reports right on TradingView.
SHANGHAI PHARMACEUTICALS HOLDING is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
601607 earnings for the last quarter are 0.30 CNY per share, whereas the estimation was 0.27 CNY resulting in a 9.59% surprise. The estimated earnings for the next quarter are 0.22 CNY per share. See more details about SHANGHAI PHARMACEUTICALS HOLDING earnings.
SHANGHAI PHARMACEUTICALS HOLDING revenue for the last quarter amounts to 70.22 B CNY, despite the estimated figure of 68.42 B CNY. In the next quarter, revenue is expected to reach 70.73 B CNY.
601607 net income for the last quarter is 1.11 B CNY, while the quarter before that showed 1.40 B CNY of net income which accounts for −20.53% change. Track more SHANGHAI PHARMACEUTICALS HOLDING financial stats to get the full picture.
SHANGHAI PHARMACEUTICALS HOLDING dividend yield was 2.38% in 2023, and payout ratio reached 39.17%. The year before the numbers were 3.20% and 35.39% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 3, 2024, the company has 48.16 K employees. See our rating of the largest employees — is SHANGHAI PHARMACEUTICALS HOLDING on this list?
Like other stocks, 601607 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI PHARMACEUTICALS HOLDING stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI PHARMACEUTICALS HOLDING technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI PHARMACEUTICALS HOLDING stock shows the buy signal. See more of SHANGHAI PHARMACEUTICALS HOLDING technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.